Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease
- PMID: 29848021
- DOI: 10.1152/ajpgi.00411.2017
Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease
Abstract
Crohn's disease (CD), characterized by discontinuous intestinal injury and inflammation, has been associated with changes in luminal microbial composition and impaired barrier function. The relationships between visual features of intestinal injury, permeability, and the mucosa-associated microbiota are unclear. Individuals undergoing routine colonoscopy (controls) and patients with CD were evaluated by clinical parameters and confocal laser scanning endomicroscopic colonoscopy (CLE). Patients with CD were categorized as either CD with no injury (CD-NI) or CD with injury (CD-I). Colonic biopsies were taken from adjacent matched sites in all individuals, and CLE images from these sites were analyzed for vascular permeability. Microbial composition was evaluated by 16S rRNA gene sequencing of the V3 region, and the mycome was identified through internal transcribed spacer 2 sequencing. Subgroup analyses were performed for histology, paracellular permeability (Ussing chamber), and encroachment of bacteria (fluorescent in situ hybridization). CD-I patients showed an altered microbial community compared with both controls and CD-NI patients, with enrichment in Escherichia and a decrease in Firmicutes, including Lachnospira, Faecalibacterium, and Blautia. In CD-I patients, bacterial encroachment to host epithelial cells was greater in sites of injury than in matched biopsy sites. Biopsies from sites of injury also demonstrated greater vascular and paracellular permeability. Overall, CD-I patients showed an altered mucosal microbial community compared with CD-NI patients and controls. Matched biopsy samples in CD-I patients revealed that sites of injury, identified endoscopically, are characterized by increased encroachment of bacteria to host epithelial cells, associated with increased paracellular and vascular permeability, which may drive inflammation in CD. NEW & NOTEWORTHY Patients with Crohn's disease (CD) with areas of colonic injury have an altered microbial community compared with patients who have no endoscopic evidence of injury or active disease. Although matched biopsies from patients with colonic injury show no differences in the mucosa-associated microbiota, injured sites are associated with increased permeability and increased encroachment. Our results support the notion that dysbiotic communities within patients with colonic injury cause or permit disruption of the mucosal and endothelial layers in CD.
Keywords: crohn's disease; dysbiosis; microbiota; permeability.
Similar articles
-
Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.World J Gastroenterol. 2019 May 14;25(18):2204-2216. doi: 10.3748/wjg.v25.i18.2204. World J Gastroenterol. 2019. PMID: 31143071 Free PMC article.
-
Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.World J Gastroenterol. 2018 Dec 14;24(46):5223-5233. doi: 10.3748/wjg.v24.i46.5223. World J Gastroenterol. 2018. PMID: 30581271 Free PMC article.
-
Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.Indian J Med Res. 2015 Jul;142(1):23-32. doi: 10.4103/0971-5916.162091. Indian J Med Res. 2015. PMID: 26261163 Free PMC article.
-
[Intestinal flora and Crohn's disease].Ann Pharm Fr. 2003 Jul;61(4):276-81. Ann Pharm Fr. 2003. PMID: 12843962 Review. French.
-
The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.Gastroenterol Clin North Am. 2017 Sep;46(3):481-492. doi: 10.1016/j.gtc.2017.05.004. Epub 2017 Jul 19. Gastroenterol Clin North Am. 2017. PMID: 28838410 Review.
Cited by
-
Association of systemic immune-inflammation index with malnutrition among Chinese hospitalized patients: a nationwide, multicenter, cross-sectional study.Front Nutr. 2024 Aug 27;11:1375053. doi: 10.3389/fnut.2024.1375053. eCollection 2024. Front Nutr. 2024. PMID: 39257607 Free PMC article.
-
Elevated risk of adverse effects from foodborne contaminants and drugs in inflammatory bowel disease: a review.Arch Toxicol. 2024 Nov;98(11):3519-3541. doi: 10.1007/s00204-024-03844-w. Epub 2024 Sep 9. Arch Toxicol. 2024. PMID: 39249550 Free PMC article. Review.
-
Microbiome in radiotherapy: an emerging approach to enhance treatment efficacy and reduce tissue injury.Mol Med. 2024 Jul 19;30(1):105. doi: 10.1186/s10020-024-00873-0. Mol Med. 2024. PMID: 39030525 Free PMC article. Review.
-
Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease.Ann Med. 2024 Dec;56(1):2338244. doi: 10.1080/07853890.2024.2338244. Epub 2024 Apr 22. Ann Med. 2024. PMID: 38648495 Free PMC article.
-
Mucosal microbiome of surgically treated terminal ileal Crohn's disease.Front Cell Infect Microbiol. 2024 Jan 12;13:1324668. doi: 10.3389/fcimb.2023.1324668. eCollection 2023. Front Cell Infect Microbiol. 2024. PMID: 38282618 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical